Shorter, cheaper liver scans for cancer patients? small study tests new approach
NCT ID NCT04973007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two different contrast agents used in liver MRI scans to see if a shorter, cheaper scan could work as well as the standard one for finding colorectal cancer that has spread to the liver. The trial planned to enroll 10 adults with suspected liver metastases, but it was terminated early. The goal was to save time and money without missing cancer spots.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
gadobenate dimeglumine (MultiHance) and gadoxetate disodium (Primovist/Eovist)
What this could lead to
If successful, this could make liver MRI scans faster, cheaper, and easier for patients while still finding cancer spread effectively.
What could go wrong
This was a very small, terminated study with only 10 participants, so results are limited and may not apply broadly. The approach may not be as accurate as the standard method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States